drugset / Trial / NCT00264225

Analgesic Effectiveness of Three Different Doses of a New Formulation of Lamaline in a Model of Painful Knee (Gonarthrosis)

NCT00264225 ↗

Phase 3 Completed Solvay Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to assess the analgesic effectiveness and safety of three different doses of a new formulation of Lamaline® versus Dafalgan® Codeine after 10 days administration in subjects with painful gonarthrosis

Timeline

Start
2005-12
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Dafalgan codeine Unknown — —
Subject Lamaline® Unknown — —

Indications